Dr. Nicholas Joseph Genova, MD

Dr. Genova practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Genova's NPI, 1366862153, was assigned on April 21, 2014. Dr. Genova graduated from State University of New York Downstate Medical Center College of Medicine in 2014. Dr. Genova holds New York license 294065.

Dr. Genova's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Genova's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Genova to 2 more clinical labs and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Genova practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Genova's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Genova is licensed in New York.

CMS data shows 140 Medicare services from Dr. Genova across 2 procedure codes in 2024, for 37 Medicare patients. Medicare paid $6,641 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Genova in 2024. The largest group is under 65, with 19 patients. 75% of them have anxiety, and 75% have depression. 68% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Genova's median patient age at 58, with 42% women.

In 2024, Dr. Genova wrote 150 Medicare Part D claims for 24 patients. 97% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $783 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Genova for performance year 2024, reported through an alternative payment model (APM). Dr. Genova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Genova as offering telehealth.

CMS Open Payments shows 1 general payment to Dr. Genova from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Alkermes, Inc. paid the most, $117.

Dr. Genova graduated from State University of New York Downstate Medical Center College of Medicine in 2014.